[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:mature-b-cell-non-hodgkin-lymphoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":37,"states":38},"Mature B-Cell Non-Hodgkin Lymphoma",4,3,[8,16,23,30],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05533775","A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed\u002FRefractory Mature B-Cell Non-Hodgkin Lymphoma",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:15:53.461103Z","2026-05-05T02:43:29.390938Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05253495","Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma",[20],"Phase 2","2026-08-26T02:19:23.493898Z","2026-05-05T02:43:26.904491Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06792734","Phase 1 Trial of BTM-3566 in Relapsed\u002FRefractory Mature B Cell Lymphomas",[27],"Phase 1","2026-08-26T02:15:48.613507Z","2026-05-05T02:43:26.709476Z",{"nct_id":31,"title":32,"phases":33,"status":34,"updated_at":35,"content_modified":36},"NCT07516353","my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults",[],"NOT_YET_RECRUITING","2026-08-26T02:16:01.079019Z","2026-05-05T02:43:29.524607Z",[],[]]